Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

LPAR1 Antikörper (Extracellular)

Dieses Kaninchen Polyklonal-Antikörper erkennt spezifisch LPAR1 in WB, IHC, FACS und LCI. Er zeigt eine Reaktivität gegenüber Ratte.
Produktnummer ABIN7043311

Kurzübersicht für LPAR1 Antikörper (Extracellular) (ABIN7043311)

Target

Alle LPAR1 Antikörper anzeigen
LPAR1 (Lysophosphatidic Acid Receptor 1 (LPAR1))

Reaktivität

  • 53
  • 21
  • 6
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
Ratte

Wirt

  • 52
  • 4
Kaninchen

Klonalität

  • 48
  • 8
Polyklonal

Konjugat

  • 25
  • 4
  • 4
  • 4
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser LPAR1 Antikörper ist unkonjugiert

Applikation

  • 39
  • 19
  • 13
  • 11
  • 11
  • 7
  • 4
  • 3
  • 3
  • 1
Western Blotting (WB), Immunohistochemistry (IHC), Flow Cytometry (FACS), Live Cell Imaging (LCI)
  • Bindungsspezifität

    • 15
    • 7
    • 5
    • 4
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 36-50, Extracellular

    Verwendungszweck

    A Rabbit Polyclonal Antibody to LPA Receptor 1 (EDG2)

    Spezifität

    Extracellular, N-terminus

    Kreuzreaktivität

    Human, Maus, Ratte

    Homologie

    Mouse - identical, human - 14,15 amino acid residues identical

    Produktmerkmale

    Anti-LPAR1 (EDG2) (extracellular) Antibody (ABIN7043311, ABIN7044566 and ABIN7044567) is a highly specific antibody directed against an epitope of the rat LPA1 receptor. The antibody can be used in western blot analysis. It has been designed against an extracellular domain and thus is highly suitable for detecting the receptor in living cells. It has been designed to recognize LPA1 receptor from human, rat, and mouse samples.

    Aufreinigung

    Affinity purified on immobilized antigen.

    Immunogen

    Immunogen: Synthetic peptide

    Immunogen Sequence: (C)RSGKYLATEWNTVSK, corresponding to amino acid residues 36-50 of rat LPA1 receptor

    Isotyp

    IgG
  • Applikationshinweise

    Antigen preadsorption control: 1 μg peptide per 1 μg antibody

    Application Dilutions Immunohistochemistry paraffin embedded sections ihc: 1:1000

    Application Dilutions Western blot wb: 1:400

    Kommentare

    Negative Control: (ABIN7235898)

    Blocking Peptide: (ABIN7235898)

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Recosntitute with double distilled water (DDW) to a concentration of 1.0 mg/mL.

    Konzentration

    1 mg/mL

    Buffer

    PBS pH 7.4

    Lagerung

    4 °C,-20 °C

    Informationen zur Lagerung

    Storage before reconstitution: The antibody ships as a lyophilized powder at room temperature. Upon arrival, it should be stored at -20°C.

    Storage after reconstitution: The reconstituted solution can be stored at 4°C for up to 1 week. For longer periods, small aliquots should be stored at -20°C. Avoid multiple freezing and thawing. Centrifuge all antibody preparations before use (10000 x g 5 min).

  • Target

    LPAR1 (Lysophosphatidic Acid Receptor 1 (LPAR1))

    Andere Bezeichnung

    LPAR1

    Hintergrund

    Lysophosphatidic acid receptor 1, LPA receptor 1, LPA-1, Gpcr91, Gpr26, VZG1,Lysophosphatidic acid is a naturally occurring lysophospholipid that activates diverse cellular actions in various cells including proliferation and morphological changes. There are currently three known genes that encode proteins of the LPA receptor family- Edg2, Edg4 and Edg7.Lysophosphatidic acid receptor 1 (also known as Lpa1), encoded by Edg2, belongs to G-coupled protein receptor (GPCR) superfamily. All three proteins share 50-54 % identical amino-acids. Lpa1 mostly activates the Gi pathway that leads to inhibition of adenylate cyclase and thus inhibition of cAMP production. Through this pathway, Lpa1 also initiates the Ras/MAP kinase cascade which is primarily responsible for increased cell proliferation1. Interestingly, binding of lysophosphatidic acid to the G13 G-protein activates the small GTP-binding protein Rho and induces the rapid remodeling of the actin cytoskeleton2.Lpa1 has been implicated in the pathogenesis of metastatic bone cancer. Silencing of Lpa1 expression in breast and ovarian cancer cells significantly alters the progression of bone metastasis through reduction of tumor burden and inhibition of bone resorption. A specific Lpa1 antagonist exhibits specificity for tumor cell-platelet interaction without abrogating normal platelet function3.

    Alternative names: LPAR1 (EDG2), Lysophosphatidic acid receptor 1, LPA receptor 1, LPA-1, Gpcr91, Gpr26, VZG1

    Gen-ID

    116744

    NCBI Accession

    NM_057159

    Pathways

    Myometrial Relaxation and Contraction, Smooth Muscle Cell Migration
Sie sind hier:
Chat with us!